The authors collected 25 Japanese acupuncture-moxibustion works of Chinese translation version in modern times (1912-1960) and investigated them from 3 aspects, named the study on the mechanisms of acupuncture and moxibustion, the explanation of basic theory and clinical treatment with acupuncture and moxibustion. Generally speaking, Japanese acupuncture-moxibustion works of Chinese translation version explained the mechanisms of acupuncture and moxibustion in terms of the theory of western medicine rather than traditional one. It proposed the study on the phenomenon of meridian and collateral, which absorbed the anatomic knowledge of western medicine in the discussion on meridians, collaterals and acupoints; introduced diagnostic methods and techniques of acupuncture and moxibustion and adopted the classification of western medicine system and the diseases in western medicine to discuss the treatment with acupuncture and moxibustion. All of these reflect the academic characteristics of acupuncture and moxibustion in Japan at those times and the position of Chinese scholars, by which the Japanese medical works were introduced for the academic innovation.

ObjectiveTo observe the clinical effect of crocin tablets （CRO） combined with micropump infusion of doxorubicin in the prevention of acute cardiotoxicity in the patients with diffuse large B-cell lymphoma （DLBCL） and explore the related mechanism. MethodThe patients with DLBCL treated in the Huangshi Central Hospital from October 2022 to October 2023 were selected， and 92 patients who met the inclusion criteria were randomly assigned to a control group and an observation group at a ratio of 1∶1， with 46 patients in each group. The control group underwent conventional intravenous infusion of doxorubicin， and the observation group received CRO combined with micropump infusion of doxorubicin. The changes of abnormal ECG， myocardial injury markers， cardiac function indicators， oxidative stress， inflammatory mediators， and hemorheological indexes before and after chemotherapy were compared between the two groups. ResultThe incidence of abnormal ECG in the observation group was 23.91% （11/46）， which was lower than that （54.35%， 25/46） in the control group （χ²=8.944， P<0.01）. On day 8 after chemotherapy， the abnormal rates of creatine kinase-MB （CK-MB） and cardiac troponin I （cTnI） in the observation group were lower than those in the control group （χ²=4.423， 4.857， both P<0.05）. Compared with the control group after chemotherapy， the observation group showed lowered level of N-terminal pro-B-type natriuretic peptide， elevated left ventricular ejection fraction and levels of total antioxidant capacity and superoxide dismutase （P<0.01）， declined levels of interleukin-6 and tumor necrosis factor-α （P<0.01）， and decreased low whole blood viscosity， high whole blood viscosity， plasma viscosity， and fibrinogen （P<0.01）. ConclusionCRO combined with micropump infusion of doxorubicin can mitigate acute cardiotoxicity， reduce the incidence of abnormal ECG， protect cardiomyocytes， and improve the cardiac function by exerting the antioxidant and anti-inflammatory effects and improving blood flow.